We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

137 hedge funds and large institutions have $1.1B invested in Imperva, Inc. in 2014 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 47 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more funds holding in top 10

Funds holding in top 10: 29 (+7)

100% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 18

82% more call options, than puts

Call options by funds: $8.34M | Put options by funds: $4.59M

65% more capital invested

Capital invested by funds: $665M → $1.1B (+$432M)

12% more funds holding

Funds holding: 122137 (+15)

4% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 47

Holders
137
Holders Change
+15
Holders Change %
+12.3%
% of All Funds
3.65%
Holding in Top 10
9
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+350%
% of All Funds
0.24%
New
36
Increased
45
Reduced
47
Closed
18
Calls
$8.34M
Puts
$4.59M
Net Calls
+$3.75M
Net Calls Change
+$5.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
76
Swiss National Bank
Switzerland
$1.04M +$16K +400 +2%
New York State Common Retirement Fund
77
New York State Common Retirement Fund
New York
$1.01M +$815K +20,365 New
California Public Employees Retirement System
78
California Public Employees Retirement System
California
$868K +$120K +2,995 +18%
RhumbLine Advisers
79
RhumbLine Advisers
Massachusetts
$856K -$22K -550 -3%
MLICM
80
Metropolitan Life Insurance Company (MetLife)
New York
$850K +$36.1K +902 +6%
MWVC
81
Morgens Waterfall Vintiadis & Co
New York
$840K +$681K +17,000 New
UBS Group
82
UBS Group
Switzerland
$815K +$659K +16,472 New
AIG
83
American International Group
New York
$694K -$22K -549 -4%
CSS
84
Cubist Systematic Strategies
Connecticut
$650K -$88.6K -2,214 -14%
Tudor Investment Corp
85
Tudor Investment Corp
Connecticut
$625K +$506K +12,636 New
HCM
86
Highbridge Capital Management
New York
$595K +$482K +12,043 New
DTL
87
Dynamic Technology Lab
Singapore
$585K +$122K +3,049 +35%
DC
88
Deere & Company
Illinois
$513K +$415K +10,373 New
Calamos Advisors
89
Calamos Advisors
Illinois
$468K +$379K +9,470 New
GT
90
Glenmede Trust
Pennsylvania
$438K
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$429K +$311K +7,780 +864%
Neuberger Berman Group
92
Neuberger Berman Group
New York
$410K +$332K +8,298 New
FMA
93
FNY Managed Accounts
New York
$346K +$120K +3,000 +75%
EGM
94
Engineers Gate Manager
New York
$340K +$275K +6,870 New
VanEck Associates
95
VanEck Associates
New York
$330K -$127K -3,161 -32%
Morgan Stanley
96
Morgan Stanley
New York
$329K -$919K -22,954 -77%
AG
97
Aperio Group
California
$319K +$259K +6,457 New
MC
98
Menta Capital
California
$312K +$252K +6,304 New
B
99
Baird
Wisconsin
$305K +$247K +6,166 New
ID
100
Integral Derivatives
New York
$294K -$52K -1,300 -18%

IMPV Hedge Fund Activity: Q4 2014 in Review

137 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q4 2014, worth a combined $1.1B — up 65% from $665M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new IMPV positions and 18 closed out — a net gain of 18 holders — while 45 added to existing stakes and 47 trimmed.

The largest buyer was Andor Capital Management, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, cutting an estimated $35.9M.

  • 137 institutional investors held Imperva, Inc. (IMPV) as of Q4 2014, up from 122 in Q3 2014.
  • Funds reported $1.1B of Imperva, Inc. stock for Q4 2014, up 65% quarter-over-quarter.
  • 36 funds opened new Imperva, Inc. positions in Q4 2014 and 18 closed out, a net change of +18 holders.
  • The largest Imperva, Inc. buyer in Q4 2014 was Andor Capital Management, an estimated $32M added.
  • The largest Imperva, Inc. seller in Q4 2014 was Fidelity Investments, an estimated $35.9M sold.

Based on aggregated 13F filings for Q4 2014.